HTFL
Heartflow, Inc. Common Stock$59.05-1.99 (-3.29%)Prev Close$60.53·MCap$5.13B·P/E—·Vol1.52M·Yield—
▲
Buys (12M)
1
$1.05M
▼
Sells (12M)
30
$141.33M
◆
Net Activity
Net Seller
$140.27M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Heartflow, Inc. Common Stock (HTFL) has been dominated by selling, with 1 insider purchase totaling $1.05M and 30 insider sales totaling $141.33M. The most recent insider transaction was by Rogers Campbell (officer: Chief Medical Officer), who sold $1.32M worth of shares on Oct 26, 2026. Heartflow, Inc. Common Stock operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $5.13B.
HTFL Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 23,933 | $55.01 | $1.32M | 73,453 |
| Oct 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $49.57 | $1.93M | 283,014 |
| Sep 21, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 19,682 | $50.15 | $987.1K | 79,956 |
| Sep 18, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 24,345 | $50.55 | $1.23M | 171,949 |
| Sep 15, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 34,975 | $50.08 | $1.75M | 184,789 |
| Sep 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $46.78 | $1.82M | 325,804 |
| Sep 10, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 6,640 | $50.03 | $332.2K | 214,503 |
| Sep 4, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 33,416 | $49.85 | $1.67M | 248,683 |
| Aug 25, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 27,230 | $50.00 | $1.36M | 360,814 |
| Aug 20, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 32,676 | $45.00 | $1.47M | 388,044 |
| Aug 19, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $41.23 | $380.1K | 86,459 |
| Aug 18, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 15,560 | $39.06 | $607.8K | 420,720 |
| Aug 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $28.31 | $638.7K | 436,280 |
| Jul 17, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $25.72 | $237.1K | 88,731 |
| Jul 13, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $27.75 | $626.1K | 435,373 |
| Jun 26, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $35.00 | $1.36M | 457,935 |
| Jun 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $28.50 | $643.0K | 496,835 |
| May 20, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $28.34 | $261.3K | 78,731 |
| May 13, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $29.12 | $657.0K | 519,397 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sell | 2,000,000 | $29.45 | $58.90M2.3% OS | 10,194,048 |
| Apr 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $26.72 | $602.9K | 549,163 |
| Mar 23, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 64,533 | $25.69 | $1.66M | 78,518-45% |
| Mar 20, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 9,725 | $25.00 | $243.1K | 571,725 |
| Mar 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 12,837 | $22.66 | $290.9K | 581,450 |
| Mar 6, 2026 | Cullivan Julie A | director | Sell | 9,122 | $25.00 | $228.1K | 27,291-25% |
| Feb 17, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 65,153 | $24.49 | $1.60M | 76,034-46% |
| Feb 12, 2026 | Rogers Campbell | Chief Medical Officer | Sell | 65,153 | $24.49 | $1.60M | 0 |
| Feb 10, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $27.46 | $619.6K | 591,656 |
| Feb 6, 2026 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sell | 2,000,000 | $28.05 | $56.10M2.3% OS | 10,448,158 |
| Feb 6, 2026 | Cullivan Julie A | director | Sell | 8,000 | $27.32 | $218.6K | 36,413 |
| Dec 17, 2025 | Lightcap Jeffrey C | Director | Buy | 40,000 | $26.34 | $1.05M | 40,000 |
HTFL Insider Buying Activity
The following table shows recent insider purchases of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Lightcap Jeffrey C | Director | Buy | 40,000 | $26.34 | $1.05M | 40,000 |
HTFL Insider Selling Activity
The following table shows recent insider sales of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 23,933 | $55.01 | $1.32M | 73,453 |
| Oct 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $49.57 | $1.93M | 283,014 |
| Sep 21, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 19,682 | $50.15 | $987.1K | 79,956 |
| Sep 18, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 24,345 | $50.55 | $1.23M | 171,949 |
| Sep 15, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 34,975 | $50.08 | $1.75M | 184,789 |
| Sep 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $46.78 | $1.82M | 325,804 |
| Sep 10, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 6,640 | $50.03 | $332.2K | 214,503 |
| Sep 4, 2026 | Verghese Vikram | officer: Chief Financial Officer | Sell | 33,416 | $49.85 | $1.67M | 248,683 |
| Aug 25, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 27,230 | $50.00 | $1.36M | 360,814 |
| Aug 20, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 32,676 | $45.00 | $1.47M | 388,044 |
| Aug 19, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $41.23 | $380.1K | 86,459 |
| Aug 18, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 15,560 | $39.06 | $607.8K | 420,720 |
| Aug 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $28.31 | $638.7K | 436,280 |
| Jul 17, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $25.72 | $237.1K | 88,731 |
| Jul 13, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $27.75 | $626.1K | 435,373 |
| Jun 26, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 38,900 | $35.00 | $1.36M | 457,935 |
| Jun 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $28.50 | $643.0K | 496,835 |
| May 20, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 9,219 | $28.34 | $261.3K | 78,731 |
| May 13, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $29.12 | $657.0K | 519,397 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sell | 2,000,000 | $29.45 | $58.90M2.3% OS | 10,194,048 |
| Apr 14, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $26.72 | $602.9K | 549,163 |
| Mar 23, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 64,533 | $25.69 | $1.66M | 78,518-45% |
| Mar 20, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 9,725 | $25.00 | $243.1K | 571,725 |
| Mar 12, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 12,837 | $22.66 | $290.9K | 581,450 |
| Mar 6, 2026 | Cullivan Julie A | director | Sell | 9,122 | $25.00 | $228.1K | 27,291-25% |
| Feb 17, 2026 | Rogers Campbell | officer: Chief Medical Officer | Sell | 65,153 | $24.49 | $1.60M | 76,034-46% |
| Feb 12, 2026 | Rogers Campbell | Chief Medical Officer | Sell | 65,153 | $24.49 | $1.60M | 0 |
| Feb 10, 2026 | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $27.46 | $619.6K | 591,656 |
| Feb 6, 2026 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sell | 2,000,000 | $28.05 | $56.10M2.3% OS | 10,448,158 |
| Feb 6, 2026 | Cullivan Julie A | director | Sell | 8,000 | $27.32 | $218.6K | 36,413 |
HTFL Insiders
Similar Stocks to HTFL
TEM
Tempus AI, Inc.
$72.82-6.35%
$13.79B
BTSG
BrightSpring Health Services, Inc. Common Stock
$66.89+9.71%
$13.24B
HNGE
Hinge Health, Inc.
$114.32-2.60%
$9.22B
HQY
HealthEquity, Inc.
$102.47+0.60%
$8.48B
DOCS
Doximity, Inc.
$32.76-2.54%
$5.84B
WAY
Waystar Holding Corp.
$28.00-0.76%
$5.37B
OMCL
Omnicell, Inc.
$36.65-0.27%
$1.67B
GDRX
GoodRx Holdings, Inc.
$3.50-1.27%
$1.21B